Seegene, Inc. (KOSDAQ: 096530)

Market Cap	1.10T
Revenue (ttm)	399.42B
Net Income (ttm)	29.47B
Shares Out	46.04M
EPS (ttm)	638.49
PE Ratio	37.43
Forward PE	35.37
Dividend	800.00 (3.31%)
Ex-Dividend Date	Dec 27, 2024

Volume	206,064
Average Volume	1,143,085
Open	24,050
Previous Close	23,900
Day's Range	24,000 - 24,450
52-Week Range	19,500 - 35,950
Beta	-1.16
RSI	47.28
Earnings Date	Feb 14, 2025

About Seegene

Seegene, Inc. manufactures and sells molecular diagnostics products worldwide. It offers IVD products comprising respiratory disease detection products for respiratory infections; gastrointestinal disease detection products for gastrointestinal tract infections; human papillomavirus detection products; sexually transmitted infections causative pathogens detection products; tuberculosis detection products; drug resistance products; Magicplex sepsis real-time test for the detection and identification of sepsis causing pathogens; and meningitis de...

• Industry: In Vitro and In Vivo Diagnostic Substances
• Founded: 2000
• Employees: 63
• Stock Exchange: KOSDAQ
• Ticker Symbol: 096530

Financial Performance

In 2023, Seegene's revenue was 367.38 billion, a decrease of -56.96% compared to the previous year's 853.56 billion. Earnings were 669.01 million, a decrease of -99.63%.